| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6070303 | Journal of the American Academy of Dermatology | 2015 | 10 Pages |
Abstract
The low incidence of adverse outcomes suggests that CCT may be more indolent than noncombined tumors. 11q13 amplification in both components supports the theory of dual differentiation from a common progenitor cell.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sapna M. MD, Chelsea BA, Oriol MD, Christina Y. BA, Lauren M. MS, Arnaud MD, PhD, Joan MD, Pedram MD,